$1.87 Billion in Sales Expected for Willis Towers Watson PLC (WLTW) This Quarter

Share on StockTwits

Equities analysts forecast that Willis Towers Watson PLC (NASDAQ:WLTW) will announce sales of $1.87 billion for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Willis Towers Watson’s earnings, with estimates ranging from $1.84 billion to $1.90 billion. Willis Towers Watson posted sales of $1.85 billion in the same quarter last year, which would indicate a positive year over year growth rate of 1.1%. The company is expected to report its next earnings results on Thursday, November 1st.

On average, analysts expect that Willis Towers Watson will report full year sales of $8.52 billion for the current financial year, with estimates ranging from $8.41 billion to $8.59 billion. For the next year, analysts expect that the firm will post sales of $8.85 billion, with estimates ranging from $8.72 billion to $8.95 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Willis Towers Watson.

Willis Towers Watson (NASDAQ:WLTW) last released its quarterly earnings results on Thursday, August 2nd. The financial services provider reported $1.70 EPS for the quarter, meeting analysts’ consensus estimates of $1.70. Willis Towers Watson had a return on equity of 9.96% and a net margin of 5.65%. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.99 billion. During the same quarter in the previous year, the company posted $1.45 EPS. The business’s revenue was up 3.7% on a year-over-year basis.

A number of equities research analysts have commented on WLTW shares. Morgan Stanley reduced their price target on Willis Towers Watson from $175.00 to $171.00 and set an “overweight” rating on the stock in a research report on Friday, August 3rd. Credit Suisse Group started coverage on Willis Towers Watson in a research report on Tuesday, August 7th. They issued a “neutral” rating and a $166.00 price target on the stock. Zacks Investment Research lowered Willis Towers Watson from a “hold” rating to a “sell” rating in a research report on Wednesday, August 8th. ValuEngine lowered Willis Towers Watson from a “hold” rating to a “sell” rating in a research report on Friday, August 3rd. Finally, BidaskClub upgraded Willis Towers Watson from a “hold” rating to a “buy” rating in a research report on Tuesday, July 24th. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. Willis Towers Watson has a consensus rating of “Hold” and a consensus target price of $172.77.

In related news, insider Adam Garrard sold 1,830 shares of the company’s stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $146.77, for a total transaction of $268,589.10. Following the sale, the insider now owns 13,739 shares in the company, valued at approximately $2,016,473.03. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.50% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the stock. Verition Fund Management LLC raised its stake in Willis Towers Watson by 146.3% during the 1st quarter. Verition Fund Management LLC now owns 12,449 shares of the financial services provider’s stock worth $1,895,000 after buying an additional 7,395 shares during the period. Aperio Group LLC raised its stake in Willis Towers Watson by 8.1% during the 1st quarter. Aperio Group LLC now owns 28,422 shares of the financial services provider’s stock worth $4,326,000 after buying an additional 2,135 shares during the period. North Run Capital LP acquired a new position in Willis Towers Watson during the 1st quarter worth approximately $7,610,000. Raymond James & Associates raised its stake in Willis Towers Watson by 0.3% during the 2nd quarter. Raymond James & Associates now owns 253,777 shares of the financial services provider’s stock worth $38,473,000 after buying an additional 813 shares during the period. Finally, Russell Investments Group Ltd. raised its stake in Willis Towers Watson by 1.1% during the 1st quarter. Russell Investments Group Ltd. now owns 350,396 shares of the financial services provider’s stock worth $53,200,000 after buying an additional 3,734 shares during the period. Institutional investors own 93.15% of the company’s stock.

Shares of NASDAQ WLTW traded up $0.15 during trading on Friday, reaching $140.94. The company had a trading volume of 1,047,600 shares, compared to its average volume of 557,522. Willis Towers Watson has a 12 month low of $139.72 and a 12 month high of $165.00. The firm has a market capitalization of $18.43 billion, a PE ratio of 16.56, a price-to-earnings-growth ratio of 1.24 and a beta of 0.88. The company has a current ratio of 2.29, a quick ratio of 2.29 and a debt-to-equity ratio of 0.44.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Sunday, September 30th will be given a dividend of $0.60 per share. The ex-dividend date is Thursday, September 27th. This represents a $2.40 annualized dividend and a dividend yield of 1.70%. Willis Towers Watson’s payout ratio is 28.20%.

About Willis Towers Watson

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. Its Human Capital and Benefits segment provides actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services.

Recommended Story: Analyst Ratings

Get a free copy of the Zacks research report on Willis Towers Watson (WLTW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Willis Towers Watson (NASDAQ:WLTW)

Receive News & Ratings for Willis Towers Watson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.